Colgate-Palmolive Company $CL Shares Purchased by Global X Japan Co. Ltd.

Global X Japan Co. Ltd. grew its position in Colgate-Palmolive Company (NYSE:CL) by 180.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 37,628 shares of the company’s stock after purchasing an additional 24,225 shares during the period. Global X Japan Co. Ltd.’s holdings in Colgate-Palmolive were worth $2,973,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of CL. Norges Bank acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter worth approximately $960,390,000. Invesco Ltd. raised its holdings in shares of Colgate-Palmolive by 13.1% in the 3rd quarter. Invesco Ltd. now owns 8,467,993 shares of the company’s stock worth $676,931,000 after purchasing an additional 978,943 shares in the last quarter. Diamond Hill Capital Management Inc. increased its holdings in shares of Colgate-Palmolive by 46.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock valued at $645,719,000 after buying an additional 2,572,796 shares in the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Colgate-Palmolive by 5.1% during the third quarter. Ameriprise Financial Inc. now owns 6,423,764 shares of the company’s stock valued at $517,167,000 after purchasing an additional 314,584 shares during the last quarter. Finally, Amundi lifted its stake in Colgate-Palmolive by 41.6% during the third quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after buying an additional 1,850,412 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 1.6%

Shares of CL opened at $84.08 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The stock has a 50 day simple moving average of $91.12 and a 200-day simple moving average of $83.38. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The stock has a market cap of $67.77 billion, a PE ratio of 32.09, a PEG ratio of 3.83 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter last year, the business posted $0.91 earnings per share. The company’s revenue was up 5.8% on a year-over-year basis. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Analysts Set New Price Targets

CL has been the subject of several research analyst reports. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a research report on Tuesday, December 9th. Jefferies Financial Group boosted their price target on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Finally, Wall Street Zen raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Saturday, March 21st. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $94.75.

Insider Activity

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares of the company’s stock, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.